Science
Mechanism of Action
Direct mechanistic action of Inositol Hexaniacinate Hexaascorbate on skin has not been elucidated in available research. Relatedly, Inositol Hexaniacinate, a niacin derivative, functions as a prodrug. It undergoes hydrolysis by plasma esterases, gradually releasing free nicotinic acid (niacin) and inositol, with niacin known to induce vasodilation and influence lipid metabolism.
Research
Clinical Evidence
Insufficient-data confidenceN/A
Transparency
Dusting Analysis
The Formula
Formulation
Stability
Information regarding the optimal pH range or stability specifically for Inositol Hexaniacinate Hexaascorbate is not available. For the related compound Inositol Hexaniacinate, limited indications suggest relative stability in food supplements with a shelf-life of 3 years, though comprehensive supporting data are not provided.
Safety
Safety Profile
Comprehensive safety assessments by regulatory bodies such as CIR, SCCS, or FDA specifically for Inositol Hexaniacinate Hexaascorbate are not documented. For Inositol (the base molecule), the CIR Expert Panel concluded it is safe for cosmetic use, with concentrations up to 4% reported in facial preparations. Oral Inositol Hexaniacinate is generally considered safe, though potential adverse effects like gastrointestinal discomfort have been noted. The dermal safety profile of this specific hexaascorbate derivative remains unestablished.
Your Skin
Skin Compatibility
Our Assessment
Verdict
Due to the complete absence of specific clinical studies, mechanistic data, and comprehensive safety evaluations for Inositol Hexaniacinate Hexaascorbate on skin, its utility in precision skincare remains unestablished.
Related
Similar Ingredients
Finding similar ingredients…